| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Cancer in the Family
|
Harding, Emilia
|
|
2016
|
17 |
10 |
p. 1359-
1 p.
|
artikel
|
| 2 |
Access to loan-related insurance for French cancer survivors
|
Dumas, Agnès
|
|
2016
|
17 |
10 |
p. 1354-1356
3 p.
|
artikel
|
| 3 |
An antidote to fluorouracil and capecitabine toxicity
|
Wilkinson, Emma
|
|
2016
|
17 |
10 |
p. e429-
1 p.
|
artikel
|
| 4 |
Antiemetic overuse in patients receiving chemotherapy
|
Das, Manjulika
|
|
2016
|
17 |
10 |
p. e428-
1 p.
|
artikel
|
| 5 |
Arginine deprivation for ASS1-deficient mesothelioma
|
Burki, Talha Khan
|
|
2016
|
17 |
10 |
p. e423-
1 p.
|
artikel
|
| 6 |
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
|
Kaufman, Howard L
|
|
2016
|
17 |
10 |
p. 1374-1385
12 p.
|
artikel
|
| 7 |
Be Here Now
|
Zajanckauskaite, Estera
|
|
2016
|
17 |
10 |
p. 1361-
1 p.
|
artikel
|
| 8 |
Cancer in patients with inherited ciliopathies: polycystic kidney disease
|
Chapman, Jeremy R
|
|
2016
|
17 |
10 |
p. 1343-1345
3 p.
|
artikel
|
| 9 |
Cancer of unknown primary: time to put the pieces of the puzzle together?
|
Economopoulou, Panagiota
|
|
2016
|
17 |
10 |
p. 1339-1340
2 p.
|
artikel
|
| 10 |
Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group
|
Kreissl, Stefanie
|
|
2016
|
17 |
10 |
p. 1453-1462
10 p.
|
artikel
|
| 11 |
Carfilzomib therapy improves quality of life in multiple myeloma
|
Das, Manjulika
|
|
2016
|
17 |
10 |
p. e427-
1 p.
|
artikel
|
| 12 |
Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma?
|
Hauschild, Axel
|
|
2016
|
17 |
10 |
p. 1337-1339
3 p.
|
artikel
|
| 13 |
Colorectal cancer trial endpoints: time for dynamic thinking?
|
Davidson, Michael
|
|
2016
|
17 |
10 |
p. 1345-1347
3 p.
|
artikel
|
| 14 |
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|
Marina, Neyssa M
|
|
2016
|
17 |
10 |
p. 1396-1408
13 p.
|
artikel
|
| 15 |
Cord blood transplant improves outcomes in leukaemia
|
Brower, Vicki
|
|
2016
|
17 |
10 |
p. e425-
1 p.
|
artikel
|
| 16 |
Correction to Lancet Oncol 2016; 17: 738
|
|
|
2016
|
17 |
10 |
p. e420-
1 p.
|
artikel
|
| 17 |
Correction to Lancet Oncol 2016; 17: 1426
|
|
|
2016
|
17 |
10 |
p. e420-
1 p.
|
artikel
|
| 18 |
Correction to Lancet Oncol 2016; 17: 1203, 06, 08, 09, 11
|
|
|
2016
|
17 |
10 |
p. e420-
1 p.
|
artikel
|
| 19 |
Correction to Lancet Oncol 2016; 17: e310
|
|
|
2016
|
17 |
10 |
p. e420-
1 p.
|
artikel
|
| 20 |
Correction to Lancet Oncol 2016; 17: e423
|
|
|
2016
|
17 |
10 |
p. e420-
1 p.
|
artikel
|
| 21 |
Daratumumab combination prolongs myeloma survival
|
Das, Manjulika
|
|
2016
|
17 |
10 |
p. e422-
1 p.
|
artikel
|
| 22 |
De-escalation of axillary surgery in early breast cancer
|
Jatoi, Ismail
|
|
2016
|
17 |
10 |
p. e430-e441
nvt p.
|
artikel
|
| 23 |
Does persistent fatigue in survivors relate to cancer?
|
Henry-Amar, Michel
|
|
2016
|
17 |
10 |
p. 1351-1352
2 p.
|
artikel
|
| 24 |
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
|
Moran, Sebastian
|
|
2016
|
17 |
10 |
p. 1386-1395
10 p.
|
artikel
|
| 25 |
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial
|
Stintzing, Sebastian
|
|
2016
|
17 |
10 |
p. 1426-1434
9 p.
|
artikel
|
| 26 |
Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis
|
Gharahkhani, Puya
|
|
2016
|
17 |
10 |
p. 1363-1373
11 p.
|
artikel
|
| 27 |
HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study
|
Hearn, Jason W D
|
|
2016
|
17 |
10 |
p. 1435-1444
10 p.
|
artikel
|
| 28 |
Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study
|
O'Brien, Susan
|
|
2016
|
17 |
10 |
p. 1409-1418
10 p.
|
artikel
|
| 29 |
Ibrutinib holds promise for patients with 17p deletion CLL
|
Ghia, Paolo
|
|
2016
|
17 |
10 |
p. 1342-1343
2 p.
|
artikel
|
| 30 |
I have no time for cancer
|
Morgan, Jules
|
|
2016
|
17 |
10 |
p. 1360-
1 p.
|
artikel
|
| 31 |
Improving cervical cancer screening in Baltic, central, and eastern European countries
|
Altobelli, Emma
|
|
2016
|
17 |
10 |
p. 1349-1350
2 p.
|
artikel
|
| 32 |
Incorrect catheter placement for drainage of malignant pericardial effusion
|
Muršić, Davorka
|
|
2016
|
17 |
10 |
p. e467-
1 p.
|
artikel
|
| 33 |
Inherited HSD3B1 polymorphisms and hormonal therapy resistance
|
Antonarakis, Emmanuel S
|
|
2016
|
17 |
10 |
p. 1347-1349
3 p.
|
artikel
|
| 34 |
International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer
|
Farge, Dominique
|
|
2016
|
17 |
10 |
p. e452-e466
nvt p.
|
artikel
|
| 35 |
Leaky transporters and sphincters in Barrett's oesophagus?
|
Meltzer, Stephen J
|
|
2016
|
17 |
10 |
p. 1336-1337
2 p.
|
artikel
|
| 36 |
Making paediatric precision oncology a reality
|
The Lancet Oncology,
|
|
2016
|
17 |
10 |
p. 1335-
1 p.
|
artikel
|
| 37 |
Maximum benefit of chemotherapy for osteosarcoma achieved—what are the next steps?
|
Kleinerman, Eugenie
|
|
2016
|
17 |
10 |
p. 1340-1342
3 p.
|
artikel
|
| 38 |
Melanoma screening by non-health-care professionals
|
Pleat, Jonathon
|
|
2016
|
17 |
10 |
p. 1352-1353
2 p.
|
artikel
|
| 39 |
Mutational subgroups for oesophageal adenocarcinoma
|
Burki, Talha Khan
|
|
2016
|
17 |
10 |
p. e426-
1 p.
|
artikel
|
| 40 |
NICE guidance on ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer
|
Hall, Caroline J
|
|
2016
|
17 |
10 |
p. 1357-1358
2 p.
|
artikel
|
| 41 |
Paintfest America
|
Kinsey, Caroline
|
|
2016
|
17 |
10 |
p. 1362-
1 p.
|
artikel
|
| 42 |
PCI in resected small-cell lung cancer
|
Knisely, Jonathan
|
|
2016
|
17 |
10 |
p. e415-
1 p.
|
artikel
|
| 43 |
PCI in resected small-cell lung cancer – Author's reply
|
Le Péchoux, Cécile
|
|
2016
|
17 |
10 |
p. e416-
1 p.
|
artikel
|
| 44 |
Predicting lung cancer prognosis using machine learning
|
Burki, Talha Khan
|
|
2016
|
17 |
10 |
p. e421-
1 p.
|
artikel
|
| 45 |
Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based study
|
Vaccarella, Salvatore
|
|
2016
|
17 |
10 |
p. 1445-1452
8 p.
|
artikel
|
| 46 |
Prophylactic radiotherapy to prevent procedure-tract metastases
|
Zalcman, G
|
|
2016
|
17 |
10 |
p. e417-
1 p.
|
artikel
|
| 47 |
Prophylactic radiotherapy to prevent procedure-tract metastases
|
Landau, David
|
|
2016
|
17 |
10 |
p. e418-
1 p.
|
artikel
|
| 48 |
Prophylactic radiotherapy to prevent procedure-tract metastases – Author's reply
|
Clive, Amelia O
|
|
2016
|
17 |
10 |
p. e419-
1 p.
|
artikel
|
| 49 |
Risk of cancer in patients with polycystic kidney disease: a propensity-score matched analysis of a nationwide, population-based cohort study
|
Yu, Tung-Min
|
|
2016
|
17 |
10 |
p. 1419-1425
7 p.
|
artikel
|
| 50 |
Sharks Get Cancer, Mole Rats Don't
|
Denny, Victoria
|
|
2016
|
17 |
10 |
p. 1359-
1 p.
|
artikel
|
| 51 |
Sorafenib plus cisplatin for hepatocellular carcinoma
|
Brower, Vicki
|
|
2016
|
17 |
10 |
p. e424-
1 p.
|
artikel
|
| 52 |
Treatment of low-risk ductal carcinoma in situ: is nothing better than something?
|
Benson, John R
|
|
2016
|
17 |
10 |
p. e442-e451
nvt p.
|
artikel
|
Tijdschrift beschrijving